These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1456183)

  • 1. Oral, anti-inflammatory activity of a potent, selective, protein kinase C inhibitor.
    Mulqueen MJ; Bradshaw D; Davis PD; Elliott L; Griffiths TA; Hill CH; Kumar H; Lawton G; Nixon JS; Sedgwick AD
    Agents Actions; 1992 Sep; 37(1-2):85-9. PubMed ID: 1456183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definition of early Ca2+ signals induced by anti-CD3 antibody in a human Jurkat T-cell line using a selective protein kinase C inhibitor, Ro 31-8425.
    Conroy LA; Merritt JE; Giafi CF; Lamont AG; Hallam TJ
    Biochem Soc Trans; 1993 Nov; 21(4):384S. PubMed ID: 8131961
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel, potent and selective inhibitors of protein kinase C show oral anti-inflammatory activity.
    Nixon JS; Bishop J; Bradshaw D; Davis PD; Hill CH; Elliott LH; Kumar H; Lawton G; Lewis EJ; Mulqueen M
    Drugs Exp Clin Res; 1991; 17(8):389-93. PubMed ID: 1822831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory properties of Gö 6850: a selective inhibitor of protein kinase C.
    Jacobson PB; Kuchera SL; Metz A; Schächtele C; Imre K; Schrier DJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):995-1002. PubMed ID: 7473193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ro 32-0432, a selective and orally active inhibitor of protein kinase C prevents T-cell activation.
    Birchall AM; Bishop J; Bradshaw D; Cline A; Coffey J; Elliott LH; Gibson VM; Greenham A; Hallam TJ; Harris W
    J Pharmacol Exp Ther; 1994 Feb; 268(2):922-9. PubMed ID: 8114006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of T-cell-receptor-stimulated bivalent-cation entry in Jurkat E6 cells: role of protein kinase C.
    Conroy LA; Merritt JE; Hallam TJ
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):671-7. PubMed ID: 7980431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel conformationally restricted protein kinase C inhibitor, Ro 31-8425, inhibits human neutrophil superoxide generation by soluble, particulate and post-receptor stimuli.
    Muid RE; Dale MM; Davis PD; Elliott LH; Hill CH; Kumar H; Lawton G; Twomey BM; Wadsworth J; Wilkinson SE
    FEBS Lett; 1991 Nov; 293(1-2):169-72. PubMed ID: 1660001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The design and biological properties of potent and selective inhibitors of protein kinase C.
    Nixon JS; Bishop J; Bradshaw D; Davis PD; Hill CH; Elliott LH; Kumar H; Lawton G; Lewis EJ; Mulqueen M
    Biochem Soc Trans; 1992 May; 20(2):419-25. PubMed ID: 1397642
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of a selective protein kinase C inhibitor, Ro 31-8425, on Mac-1 expression and adhesion of human neutrophils.
    Sullivan JA; Merritt JE; Budd JM; Booth RF; Hallam TJ
    Eur J Immunol; 1994 Mar; 24(3):621-6. PubMed ID: 8125132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RO 31-8220 and RO 31-7549 show improved selectivity for protein kinase C over staurosporine in macrophages.
    Dieter P; Fitzke E
    Biochem Biophys Res Commun; 1991 Nov; 181(1):396-401. PubMed ID: 1958208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K252a is a potent and selective inhibitor of phosphorylase kinase.
    Elliott LH; Wilkinson SE; Sedgwick AD; Hill CH; Lawton G; Davis PD; Nixon JS
    Biochem Biophys Res Commun; 1990 Aug; 171(1):148-54. PubMed ID: 2393389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional significance of protein kinase C in human T-cell activation: a new therapeutic class?
    Hallam TJ
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S131-4. PubMed ID: 8324939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
    Tamir A; Granot Y; Isakov N
    J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C.
    Wilkinson SE; Parker PJ; Nixon JS
    Biochem J; 1993 Sep; 294 ( Pt 2)(Pt 2):335-7. PubMed ID: 8373348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ro 31-6045, the inactive analogue of the protein kinase C inhibitor Ro 31-8220, blocks in vivo activation of p70(s6k)/p85(s6k): implications for the analysis of S6K signalling.
    Marmy-Conus N; Hannan KM; Pearson RB
    FEBS Lett; 2002 May; 519(1-3):135-40. PubMed ID: 12023032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The staurosporine analog, Ro-31-8220, induces apoptosis independently of its ability to inhibit protein kinase C.
    Han Z; Pantazis P; Lange TS; Wyche JH; Hendrickson EA
    Cell Death Differ; 2000 Jun; 7(6):521-30. PubMed ID: 10822275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of rabbit aortic smooth muscle cell proliferation by selective inhibitors of protein kinase C.
    Newby AC; Lim K; Evans MA; Brindle NP; Booth RF
    Br J Pharmacol; 1995 Apr; 114(8):1652-6. PubMed ID: 7599935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of protein kinase C. Effect on platelet-activating-factor-induced platelet functional responses.
    Murphy CT; Westwick J
    Biochem J; 1992 Apr; 283 ( Pt 1)(Pt 1):159-64. PubMed ID: 1567363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a novel COX-2 inhibitor as an orally potent anti-pyretic and anti-inflammatory drug: design, synthesis, and structure-activity relationship.
    Hayashi S; Sumi Y; Ueno N; Murase A; Takada J
    Biochem Pharmacol; 2011 Oct; 82(7):755-68. PubMed ID: 21741371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of protein kinase C inhibitors on chemokine production in human synovial fibroblasts.
    Jordan NJ; Watson ML; Yoshimura T; Westwick J
    Br J Pharmacol; 1996 Mar; 117(6):1245-53. PubMed ID: 8882622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.